bioRxiv · 10.64898/2026.03.06.710108
Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response
Abstract
Psilocybin has antidepressant effects, but its 5-HT2AR-mediated perceptual effects limit tolerability. We combined psilocybin with a phosphodiesterase-9 inhibitor (PDE9i) and observed suppression of head-twitch response, but maintenance of antidepressant-like behavior. Proteomics showed that PDE9i-psilocybin reduced 5-HT2AR-mediated pathways while enhancing synaptogenesis. These results suggest that PDE9i-psilocybin represents a promising therapeutic strategy.
Explore related subjects
Keep this discovery
Explore connections, maps & timelines
Floris, G., Jefferson, S. J., Rondeau, J., Menniti, F. S., Kwan, A. C., De Aquino, J. P., Krystal, J. H., Pittenger, C., Kaye, A. P.. 2026-03-10. Enhancing cGMP signaling with psilocybin reduces head twitch and restructures the synaptic proteome while maintaining antidepressant response. https://doi.org/10.64898/2026.03.06.710108
Cite the original work for its findings. Save a collection to share your selection of sources.